Humulin N

— THERAPEUTIC CATEGORIES —
  • Diabetes

Humulin N Generic Name & Formulations

General Description

Insulin isophane suspension (NPH) (human, rDNA origin) 100 Units/mL; inj.

How Supplied

Vials 70/30, N, R (U-100)—3mL, 10mL; R (U-500)—20mL; KwikPen (70/30, N)—5x3mL; R (U-500)—2x3mL

Manufacturer

Humulin N Indications

Indications

Diabetes.

Humulin N Dosage and Administration

Adult

Individualize. SC inj only. Rotate inj sites. Onset 1–2hrs, peak 6–12hrs, duration 18–24hrs.

Children

Not established.

Humulin N Contraindications

Contraindications

During episodes of hypoglycemia.

Humulin N Boxed Warnings

Not Applicable

Humulin N Warnings/Precautions

Warnings/Precautions

Instruct patients on proper administration of insulin, check insulin label before each injection, and management of hypoglycemia. Do not reuse or share pens, needles, or syringes between patients, even if the needle is changed. Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis. Increased risk of hyperglycemia or hypoglycemia if changes in physical activity, meal patterns, concomitant medications, renal or hepatic function, insulin regimen, administration site, and if acute illness occurs: monitor glucose more frequently and may need to adjust dose. Monitor potassium levels in patients at risk for hypokalemia (eg, concomitant K+-lowering or K+-sensitive drugs). Discontinue if hypersensitivity reactions occur. Renal or hepatic impairment. Elderly. Pregnancy. Nursing mothers.

Humulin N Pharmacokinetics

See Literature

Humulin N Interactions

Interactions

Concomitant thiazolidinediones (TZDs) may cause fluid retention and heart failure; consider dose reduction or discontinue TZDs. Increased risk of hypoglycemia with concomitant antidiabetics, ACEIs, ARBs, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (eg, octreotide), sulfonamide antibiotics. Reduced efficacy with concomitant atypical antipsychotics (eg, olanzapine, clozapine), steroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, protease inhibitors, somatropin, sympathomimetics (eg, albuterol, epinephrine, terbutaline), thyroid hormones. Variable effects with β-blockers, clonidine, lithium salts, alcohol, pentamidine. Concomitant β-blockers, clonidine, guanethidine, reserpine may blunt hypoglycemia. Onset may be delayed if regular insulin is mixed with zinc insulin. Regular and NPH insulins may be mixed and used immediately or stored for future use.

Humulin N Adverse Reactions

Adverse Reactions

Hypoglycemia, allergic reactions, inj site reactions, lipodystrophy, pruritus, rash, weight gain, edema, hypokalemia.

Humulin N Clinical Trials

See Literature

Humulin N Note

Not Applicable

Humulin N Patient Counseling

See Literature

Images